Myte, Robin
Eriksson, John
Rensfeldt, Martin
Jiang, Yunyun
AL-Shurbaji, Ayman
Nyström, Per
Article History
Received: 6 May 2025
Accepted: 13 October 2025
First Online: 10 November 2025
Declarations
:
: All authors are former or current employees and stockholders of AstraZeneca.
: Trial protocols for PRIORITIZE-HF were approved by institutional ethics committees.